CCCC - C4 Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.00
DETAILS
HIGH:
$7.00
LOW:
$7.00
MEDIAN:
$7.00
CONSENSUS:
$7.00
UPSIDE:
96.63%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 35.9 | 35.6 | 20.8 | 31.1 | 45.8 | 33.2 | 21.4 | 19.4 |
| Cost of Revenue | 8.0 | 0 | 7.7 | 0 | 0 | 78.4 | 0 | 28.6 |
| Gross Profit | 28.0 | 35.6 | 13.0 | 31.1 | 45.8 | (45.2) | 21.4 | (9.2) |
| Operating Expenses | ||||||||
| R&D Expenses | 104.2 | 110.6 | 117.7 | 117.8 | 94.7 | 78.4 | 48.1 | 28.6 |
| SG&A Expenses | 36.2 | 42.1 | 42.1 | 42.8 | 33.3 | 15.2 | 8.8 | 7.2 |
| Other Expenses | (8.0) | 2.4 | (7.7) | 0 | 0 | (78.4) | 0 | (0.0) |
| Operating Expenses | 132.5 | 155.2 | 152.1 | 160.6 | 127.9 | 15.2 | 56.8 | 35.8 |
| Operating Income | ||||||||
| Operating Income | (104.5) | (119.6) | (139.0) | (129.5) | (82.1) | (60.4) | (35.5) | (16.4) |
| Interest Expense | 0 | 0 | 1.4 | 2.2 | 2.1 | 1.2 | 0 | 0 |
| Interest Income | 0 | 14.4 | 9.8 | 3.6 | 0.4 | 0.4 | 1.8 | 0.7 |
| Profitability | ||||||||
| EBITDA | (102.9) | (103.4) | (122.1) | (124.3) | (80.3) | (58.8) | (31.7) | (15.1) |
| EBIT | (104.9) | (105.2) | (129.8) | (126.0) | (81.7) | (60.4) | (33.3) | (16.4) |
| Income Before Tax | (104.9) | (105.2) | (131.2) | (128.2) | (83.9) | (65.7) | (33.3) | (15.7) |
| Income Tax Expense | 0.1 | 0.1 | 1.3 | 0 | 0 | 0.6 | 0.8 | 0 |
| Net Income | (105.0) | (105.3) | (132.5) | (128.2) | (83.9) | (66.3) | (34.1) | (15.7) |
| Per Share Data | ||||||||
| EPS (Basic) | -1.27 | -1.52 | -2.67 | -2.62 | -1.82 | -1.54 | -0.79 | -1.06 |
| EPS (Diluted) | -1.27 | -1.52 | -2.67 | -2.62 | -1.82 | -1.54 | -0.79 | -1.06 |
| Shares Outstanding | 82.9 | 69.4 | 49.6 | 48.9 | 46.0 | 43.1 | 43.0 | 14.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 74.6 | 55.5 | 126.6 | 29.8 | 76.1 | 181.7 | 90.5 | 36.3 |
| Short-Term Investments | 173.9 | 189.4 | 127.1 | 246.4 | 233.2 | 190.0 | 0 | 0 |
| Net Receivables | 2.4 | 3.1 | 11.8 | 1.5 | 5.7 | 4.5 | 4.6 | 86.4 |
| Inventory | 0 | 0 | 0 | (61.0) | 0 | 0 | 0 | 0 |
| Other Current Assets | 7.2 | 9.8 | 5.7 | 70.9 | 0 | 0 | 0 | 0 |
| Total Current Assets | 258.1 | 257.8 | 271.2 | 287.6 | 325.7 | 381.0 | 96.8 | 123.5 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 45.3 | 63.4 | 71.1 | 77.5 | 35.1 | 16.6 | 18.9 | 20.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 22.4 | 28.0 | 61.0 | 142.2 | 0 | 0 | 2.6 |
| Other Non-Current Assets | 55.7 | 6.1 | 6.2 | 4.8 | 3.8 | 2.6 | 2.6 | 0 |
| Total Non-Current Assets | 101.0 | 91.8 | 105.3 | 143.3 | 181.1 | 19.1 | 21.5 | 23.0 |
| Total Assets | 359.1 | 349.6 | 376.5 | 430.8 | 506.8 | 400.1 | 118.3 | 146.5 |
| Current Liabilities | ||||||||
| Account Payables | 0.9 | 1.3 | 1.4 | 1.2 | 4.5 | 5.7 | 5.4 | 1.2 |
| Short-Term Debt | 6.4 | 0 | 0 | 2.3 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 12.5 | 18.7 | 15.5 | 16.6 | 31.8 | 27.6 | 20.7 | 19.1 |
| Other Current Liabilities | 13.3 | 9.3 | 9.4 | 3.1 | 5.5 | 4.2 | 3.3 | 1.3 |
| Total Current Liabilities | 33.0 | 45.2 | 42.8 | 44.5 | 51.2 | 43.9 | 33.6 | 23.9 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 9.2 | 10.8 | 10.1 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (13.7) |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 111.0 | 111.0 |
| Total Non-Current Liabilities | 69.5 | 88.4 | 87.6 | 97.1 | 65.9 | 75.5 | 196.6 | 202.3 |
| Total Liabilities | 102.5 | 133.6 | 130.3 | 141.6 | 117.2 | 119.3 | 230.2 | 226.2 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | (738.7) | (633.7) | (528.4) | (395.9) | (267.7) | (183.8) | (117.5) | (83.4) |
| Accumulated Other Comprehensive Income | 0.1 | 0.1 | (0.1) | (4.1) | (0.8) | 0.0 | 0 | (2.5) |
| Total Stockholders' Equity | 256.6 | 216.0 | 246.1 | 289.2 | 389.6 | 280.8 | (112.0) | (79.8) |
| Total Liabilities & Equity | 359.1 | 349.6 | 376.5 | 430.8 | 506.8 | 400.1 | 118.3 | 146.5 |
| Debt Metrics | ||||||||
| Total Debt | 60.0 | 65.8 | 71.0 | 87.2 | 42.9 | 22.9 | 13.7 | 14.5 |
| Net Debt | (14.6) | 10.3 | (55.6) | 57.4 | (33.2) | (158.8) | (76.8) | (21.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (105.0) | (105.3) | (132.5) | (128.2) | (83.9) | (66.3) | (34.1) | (15.7) |
| Depreciation & Amortization | 2.0 | 1.8 | 1.9 | 1.7 | 1.5 | 1.6 | 1.6 | 1.3 |
| Stock-Based Compensation | 19.1 | 29.7 | 27.2 | 30.0 | 21.5 | 3.4 | 1.6 | 0.6 |
| Change in Working Capital | (29.3) | 7.6 | (6.9) | (16.8) | (30.1) | (13.2) | 85.0 | (5.6) |
| Other Non-Cash Items | 14.5 | 1.0 | 3.5 | 7.3 | 2.1 | 1.6 | 1.1 | 2.4 |
| Operating Cash Flow | (98.7) | (65.2) | (106.8) | (105.9) | (87.0) | (67.2) | 55.6 | (17.0) |
| Investing Activities | ||||||||
| Capital Expenditure | (0.6) | (0.2) | (1.7) | (5.5) | (1.3) | (0.7) | (1.3) | (2.7) |
| Acquisitions | 0 | 0 | 0 | (63.9) | 188.1 | 189.9 | 0.1 | 0 |
| Purchases of Investments | (227.1) | (284.3) | (129.9) | (219.5) | (537.7) | (293.9) | (79) | (5.0) |
| Sales/Maturities of Investments | 219.1 | 233.2 | 290.0 | 283.4 | 349.7 | 104 | 78.7 | 44.6 |
| Other Investing Activities | 0 | 0 | 0 | 63.9 | (188.1) | (189.9) | 0 | 39.6 |
| Investing Cash Flow | (8.6) | (51.3) | 158.3 | 58.4 | (189.3) | (190.5) | (1.6) | 36.9 |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 0 | (12.5) | 0 | 0 | 12.0 | 0 | 0 |
| Stock Repurchased | (0.2) | (0.2) | (0.1) | 0 | 0 | (0.2) | (0.0) | (0.1) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.3 | 1.2 | 0.4 | 0.4 | 1.9 | (3.4) | 0.3 | (0.1) |
| Financing Cash Flow | 126.4 | 45.3 | 45.5 | 1.1 | 171.4 | 348.9 | 0.2 | 2.0 |
| Cash Position | ||||||||
| Net Change in Cash | 19.1 | (71.1) | 97 | (46.4) | (104.9) | 91.2 | 54.2 | 21.9 |
| Cash at Beginning | 58.9 | 130.0 | 33.0 | 79.4 | 184.3 | 93.1 | 38.9 | 17.0 |
| Cash at End | 78.0 | 58.9 | 130.0 | 33.0 | 79.4 | 184.3 | 93.1 | 38.9 |
| Free Cash Flow | (99.3) | (65.3) | (108.5) | (111.4) | (88.2) | (67.9) | 54.3 | (19.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 35.9 | 35.6 | 20.8 | 31.1 | 45.8 | 33.2 | 21.4 | 19.4 |
| Gross Profit | 28.0 | 35.6 | 13.0 | 31.1 | 45.8 | (45.2) | 21.4 | (9.2) |
| Operating Income | (104.5) | (119.6) | (139.0) | (129.5) | (82.1) | (60.4) | (35.5) | (16.4) |
| Net Income | (105.0) | (105.3) | (132.5) | (128.2) | (83.9) | (66.3) | (34.1) | (15.7) |
| EPS (Diluted) | -1.27 | -1.52 | -2.67 | -2.62 | -1.82 | -1.54 | -0.79 | -1.06 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 74.6 | 55.5 | 126.6 | 29.8 | 76.1 | 181.7 | 90.5 | 36.3 |
| Total Assets | 359.1 | 349.6 | 376.5 | 430.8 | 506.8 | 400.1 | 118.3 | 146.5 |
| Total Debt | 60.0 | 65.8 | 71.0 | 87.2 | 42.9 | 22.9 | 13.7 | 14.5 |
| Stockholders' Equity | 256.6 | 216.0 | 246.1 | 289.2 | 389.6 | 280.8 | (112.0) | (79.8) |
| Cash Flow | ||||||||
| Operating Cash Flow | (98.7) | (65.2) | (106.8) | (105.9) | (87.0) | (67.2) | 55.6 | (17.0) |
| Capital Expenditure | (0.6) | (0.2) | (1.7) | (5.5) | (1.3) | (0.7) | (1.3) | (2.7) |
| Free Cash Flow | (99.3) | (65.3) | (108.5) | (111.4) | (88.2) | (67.9) | 54.3 | (19.7) |